Developing next generation immunomodulatory drugs and their combinations in multiple myeloma
Sign Up to like & getrecommendations! Published in 2021 at "Oncotarget"
DOI: 10.18632/oncotarget.27973
Abstract: Multiple Myeloma (MM) is an incurable malignancy with current treatment choices primarily comprising combination regimens implemented with a risk-adapted approach. Cereblon (CRBN)-targeting immunomodulatory agents (IMiDs®) lenalidomide (LEN) and pomalidomide (POM) play a central role in… read more here.
Keywords: multiple myeloma; drug; developing next; immunomodulatory ... See more keywords
Novel Strategies for Developing Next-Generation Vaccines to Combat Infectious Viral Diseases
Sign Up to like & getrecommendations! Published in 2025 at "Vaccines"
DOI: 10.3390/vaccines13090979
Abstract: The development of viral vaccines faces persistent scientific and logistical challenges, particularly in the wake of the COVID-19 pandemic. This review critically examines emerging strategies to overcome key barriers in viral vaccine design and deployment.… read more here.
Keywords: novel strategies; next generation; generation vaccines; developing next ... See more keywords